LEADER 03389nam  2200673 a 450 
001 9910450500603321
005 20200520144314.0
010   $a1-280-19787-0
010   $a9786610197873
010   $a1-4051-4606-0
010   $a1-4237-1777-5
035   $a(CKB)1000000000009157
035   $a(EBL)233112
035   $a(OCoLC)475939740
035   $a(SSID)ssj0000257608
035   $a(PQKBManifestationID)11193224
035   $a(PQKBTitleCode)TC0000257608
035   $a(PQKBWorkID)10254089
035   $a(PQKB)11471854
035   $a(MiAaPQ)EBC233112
035   $a(MiAaPQ)EBC5247562
035   $a(Au-PeEL)EBL233112
035   $a(CaPaEBR)ebr10033058
035   $a(OCoLC)437147416
035   $a(Au-PeEL)EBL5247562
035   $a(CaONFJC)MIL19787
035   $a(EXLCZ)991000000000009157
100   $a20030609d2002      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 04$aThe textbook of pharmaceutical medicine$b[electronic resource]
205   $a4th ed. /$bedited by John P. Griffin and John O'Grady.
210   $aLondon $cBMJ Books$d2002
215   $a1 online resource (896 p.)
300   $aIncludes index.
300   $aPrevious ed.: / edited by J.P. Griffin, J. O'Grady, P.F. D'Arcy. Belfast : Queen's University of Belfast, c1998.
311   $a0-7279-1523-1 
327   $aContents; Contributors; Preface; Acknowledgements; The editors; 1: Discovery of new medicines; 2: Pharmaceutical development; 3: Toxicity testing; 4: Exploratory development; 5: Clinical pharmacokinetics; 6: Clinical trials and good clinical practice; 7: Medical statistics; 8: Development of medicines: full development; 9: The medical department; 10: Medical marketing; 11: Information and promotion; 12: The supply of unlicensed medicines for particular patient use; 13: Legal and ethical issues relating to medicinal products; 14: The safety of medicines
327   $a15: The development of the control of human medicines in Europe from classical times to the year 200016: Technical requirements for registration of pharmaceuticals for human use: the ICH process and the common technical document; 17: The regulation of drug products by the United States Food and Drug Administration; 18: The US FDA in the drug development, evaluation and approval process; 19: Regulatory and clinical trial systems in Japan; 20: Economics of healthcare; 21: Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective); Appendix 1; Appendix 2
327   $aPRESCRIPTION MEDICINES CODE OF PRACTICE AUTHORITY Constitution and ProcedureIndex
330   $aThis edition has totally revised chapters on drug regulation in the USA, with new contributor, Dr Peter Barton Hutt formerly FDA Special Counsel. New contributions regarding pharmaco-economics are covered in two new chapters.
606   $aPharmaceutical chemistry
606   $aPharmacology
608   $aElectronic books.
615  0$aPharmaceutical chemistry.
615  0$aPharmacology.
676   $a615.1
701   $aGriffin$b J. P$g(John Parry)$0857365
701   $aO'Grady$b John$0857366
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910450500603321
996   $aThe textbook of pharmaceutical medicine$91914308
997   $aUNINA